Cargando…

Age is associated with prognosis in serous ovarian carcinoma

PURPOSE: The survival duration of elderly patients with epithelial ovarian carcinoma is shorter than that of their younger counterparts. This variation in survival duration is likely attributed to differences in the distribution of histological type or grade, International Federation of Gynecology a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Fei, Xu, Xia, Lv, Mengmeng, Ren, Binhui, Wang, Yan, Guo, Wenwen, Feng, Jifeng, Chen, Xiaoxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469143/ https://www.ncbi.nlm.nih.gov/pubmed/28606125 http://dx.doi.org/10.1186/s13048-017-0331-6

Ejemplares similares

Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2016)

The significance of the alteration of 8-OHdG in serous ovarian carcinoma
por: Xu, Xia, et al.
Publicado: (2013)

Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma
por: Ren, Xinxin, et al.
Publicado: (2021)

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
por: Cui, Xuelian, et al.
Publicado: (2015)

Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma
por: Li, Li, et al.
Publicado: (2023)

Pathogenic Heteroplasmic Somatic Mitochondrial DNA Mutation Confers Platinum-Resistance and Recurrence of High-Grade Serous Ovarian Cancer
por: Ni, Jing, et al.
Publicado: (2020)

Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations
por: Voutsadakis, Ioannis A.
Publicado: (2016)

Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Efficacy of Postoperative Hormone Replacement Therapy on Prognosis of Patients with Serous Ovarian Carcinoma
por: Zhang, Yong-Li, et al.
Publicado: (2016)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

Effect of Rho GTPase activating protein 9 combined with preoperative ratio of platelet distribution width to platelet count on prognosis of patients with serous ovarian cancer
por: Shen, Yang, et al.
Publicado: (2021)

Identification of metastasis and prognosis-associated genes for serous ovarian cancer
por: Yang, Yijun, et al.
Publicado: (2020)

Low expression of acyl-CoA thioesterase 13 is associated with poor prognosis in ovarian serous cystadenocarcinoma
por: Lv, Xiaofeng, et al.
Publicado: (2023)

High Serpin Family A Member 10 Expression Confers Platinum Sensitivity and Is Associated With Survival Benefit in High-Grade Serous Ovarian Cancer: Based on Quantitative Proteomic Analysis
por: Guo, Wenwen, et al.
Publicado: (2021)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

The Role of Mesothelin Expression in Serous Ovarian Carcinoma: Impacts on Diagnosis, Prognosis, and Therapeutic Targets
por: Giordano, Giovanna, et al.
Publicado: (2022)

Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
por: Kim, Jihye, et al.
Publicado: (2018)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Gene Expression Subtyping Reveals Immune alterations:TCGA Database for Prognosis in Ovarian Serous Cystadenocarcinoma
por: Feng, Chunxia, et al.
Publicado: (2021)

Lysophosphatidic Acid-Induced Transcriptional Profile Represents Serous Epithelial Ovarian Carcinoma and Worsened Prognosis
por: Murph, Mandi M., et al.
Publicado: (2009)

Morphological and molecular basis of ovarian serous carcinoma
por: Rosen, Daniel G, et al.
Publicado: (2010)

Architectural Histopathological Changes in Ovarian Serous Carcinomas
por: DOCHIȚ, C., et al.
Publicado: (2018)

A Comprehensive Review of Ovarian Serous Carcinoma
por: Hatano, Yuichiro, et al.
Publicado: (2019)

Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer
por: Yang, Hua, et al.
Publicado: (2022)

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
por: Ducie, Jennifer, et al.
Publicado: (2017)

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio is associated with sensitivity to platinum-based chemotherapy and prognosis in patients with advanced serous ovarian carcinoma
por: Fukuda, Takeshi, et al.
Publicado: (2021)

Expression and molecular profiles of the AlkB family in ovarian serous carcinoma
por: Cai, Yuan, et al.
Publicado: (2021)

Two protein-coding genes act as a novel clinical signature to predict prognosis in patients with ovarian serous cystadenocarcinoma
por: Zhang, Jue, et al.
Publicado: (2018)

Single‐cell transcriptomes reveal heterogeneity of high‐grade serous ovarian carcinoma
por: Hao, Qian, et al.
Publicado: (2021)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
por: Shimizu, Maho, et al.
Publicado: (2021)

Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma
por: Norris, Eric J, et al.
Publicado: (2019)

Lipid Droplet Accumulation Independently Predicts Poor Clinical Prognosis in High-Grade Serous Ovarian Carcinoma
por: Iwahashi, Naoyuki, et al.
Publicado: (2021)

Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma
por: Ye, Lele, et al.
Publicado: (2022)

Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2021)

Bioinformatics analysis of gene expression profile of serous ovarian carcinomas to screen key genes and pathways
por: Fei, Hongjun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nm5ge885rbkmjg5f6gagluefr6